LSPR SEC filings, in plain English
Everything Larkspur Health Acquisition Corp. has filed with the SEC that we hold — 40 filings, newest first, 3 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: ZyVersa Therapeutics, Inc., the Larkspur Health Acquisition Corp. successor, reported under Item 8.01 that effective July 16, 2026 its common stock ceased trading on the OTCQB Venture Market and commenced trading on the OTC Pink Limited Market. The cover page confirms the stock is now quoted on OTC Pink Limited. No other events, financial figures or remediation steps are disclosed in the report, which is signed by Chief Executive Officer Stephen Glover. Why it matters: This is a second downgrade in venue, not a first: the company had already fallen from a national exchange to OTCQB, and OTC Pink Limited sits below that, reserved for issuers not meeting OTCQB's minimum bid price and reporting standards. For anyone holding the former LSPR securities it means thinner quotes, wider spreads, loss of many broker platforms and exclusion from most institutional mandates. There is no trust or floor left, so the venue itself is now the main determinant of whether a position can be exited.
What changed: ZyVersa Therapeutics, the Larkspur Health Acquisition Corp. successor, reported that on July 8, 2026 independent director Min Chul Park resigned from the board and its compensation and nominating committees for personal reasons, with no disagreement. It also disclosed cost-cutting while it seeks capital: CEO Stephen Glover and CFO Peter Wolfe each voluntarily took reduced pay given limited cash. Measures under consideration include selling the VAR 200 or IC 100 product candidates, cutting headcount, and possibly going dark by suspending Exchange Act reporting under Rule 12h-3. Why it matters: Executives cutting their own pay and a board openly weighing the sale of both lead assets is a company in liquidity distress, not one optimising costs. The most consequential item is the possibility of going dark under Rule 12h-3 — suspending Exchange Act reporting would leave holders of the former LSPR equity with no audited financials, no periodic disclosure and a security that most brokers cannot quote. Eight days later the stock dropped from OTCQB to OTC Pink Limited.
going-concern doubtnothing moved · 1 with no prior record of ours
- Going-concern doubt
- stated · unchanged
The clause …“or attain profitable operations. The aforementioned conditions raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance date of these financial statements. Note”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
going-concern doubtnothing moved · 1 with no prior record of ours
- Going-concern doubt
- stated · unchanged
The clause …“success of our efforts to raise additional capital. These uncertainties raise substantial doubt about our ability to continue as a going concern for 12 months after the issuance date of our financial statements. The accompanying”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
going-concern doubtnothing moved · 1 with no prior record of ours
- Going-concern doubt
- stated · unchanged
The clause …“or attain profitable operations. The aforementioned conditions raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance date of these financial statements. Note”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
going-concern doubtnothing moved · 1 with no prior record of ours
- Going-concern doubt
- stated · unchanged
The clause …“or attain profitable operations. The aforementioned conditions raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance date of these financial statements. Note”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
going-concern doubtnothing moved · 1 with no prior record of ours
- Going-concern doubt
- stated · unchanged
The clause …“or attain profitable operations. The aforementioned conditions raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance date of these financial statements. Note”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: ZyVersa Therapeutics, Inc., the successor to Larkspur Health Acquisition Corp., called its 2025 annual meeting for Wednesday, June 11, 2025 at 9:00 AM Eastern Time in virtual-only format, record date April 15, 2025. Proposal 4 approves shares issued under an inducement letter entered with certain warrant holders on November 5, 2024 under Nasdaq Listing Rule 5635(d), and Proposal 5 approves up to 2,105,265 additional shares issuable on exercise of warrants, with forms of Series A-2 and Series A-3 Warrants attached as annexes. Why it matters: Two separate warrant approvals on one ballot, layered on top of a November 2024 inducement that already repriced existing warrants, describe a company refinancing the same instruments repeatedly - each round issuing new warrants to persuade holders to exercise old ones. With a going-concern qualification and no trust remaining from the Larkspur SPAC, that cycle is the only funding available, and each turn deepens the dilution.
What changed vs 2025-01-17going concern APPEAREDgoing-concern doubt1 moved
- Going-concern doubt
- not statedstated
SpacBrain reads this as the substantial-doubt sentence is in this filing and not in the previous one.
The clause …“except for the inclusion of an explanatory paragraph regarding the substantial doubt about the Company’s ability to continue as a going concern. During the Company’s two most recent fiscal years ended December 31,”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.